CIK 0001326110 · Large accelerated filer
ImmunityBio, Inc.
Sign in to watch- Ticker
- IBRX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 431979754
- Phone
- (844) 696-5235
- Business address
- 3530 JOHN HOPKINS COURT, SAN DIEGO, CA, 92121
- Former names
- NantKwest, Inc., Conkwest, Inc., ZelleRx Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,119,848
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,119,848. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-02-22 | Adcock Richard CEO & President | Grant or award · Stock Option (right to buy) | +1,591,463 | 1,591,463 | ||
| 2024-02-22 | SOON-SHIONG PATRICK See remarks | Grant or award · Restricted Stock Units | +342,987 | 342,987 | ||
| 2024-02-22 | SOON-SHIONG PATRICK See remarks | Grant or award · Stock Option (right to buy) | +1,193,597 | 1,193,597 | ||
| 2024-02-05 | Adcock Richard CEO & President | Option exercise | +83,334 | 286,303 | ||
| 2024-02-05 | Adcock Richard CEO & President | Shares withheld for taxes | −43,165 | $4.04 | $174K | 243,138 |
| 2024-02-05 | Adcock Richard CEO & President | Option exercise · Restricted Stock Units | −83,334 | 0 | ||
| 2024-01-31 | Simon Barry J. Director | Option exercise | +57,200 | 3,145,855 | ||
| 2024-01-31 | Simon Barry J. Director | Shares withheld for taxes | −22,094 | $3.36 | $74K | 3,123,761 |
| 2024-01-31 | Simon Barry J. Director | Option exercise · Restricted Stock Units | −57,200 | 0 | ||
| 2024-01-31 | Sachs David C. Chief Financial Officer | Option exercise | +70,745 | 212,673 | ||
| 2024-01-31 | Sachs David C. Chief Financial Officer | Shares withheld for taxes | −26,835 | $3.36 | $90K | 185,838 |
| 2024-01-31 | Sachs David C. Chief Financial Officer | Option exercise · Restricted Stock Units | −70,745 | 0 | ||
| 2024-01-31 | LAUER REGAN J Chief Accounting Officer | Option exercise | +32,872 | 107,804 | ||
| 2024-01-31 | LAUER REGAN J Chief Accounting Officer | Shares withheld for taxes | −13,470 | $3.36 | $45K | 94,334 |
| 2024-01-31 | LAUER REGAN J Chief Accounting Officer | Option exercise · Restricted Stock Units | −32,872 | 0 | ||
| 2023-12-31 | Sachs David C. Chief Financial Officer | Option exercise | +30,397 | 152,439 | ||
| 2023-12-31 | Sachs David C. Chief Financial Officer | Shares withheld for taxes | −10,511 | $5.02 | $53K | 141,928 |
| 2023-12-31 | Sachs David C. Chief Financial Officer | Option exercise · Restricted Stock Units | −30,397 | 106,396 | ||
| 2023-12-31 | Adcock Richard CEO & President | Option exercise | +34,483 | 220,065 | ||
| 2023-12-31 | Adcock Richard CEO & President | Shares withheld for taxes | −17,096 | $5.02 | $86K | 202,969 |
Page 8 of 12 · 226 trades